Final Safety and Efficacy Analysis of a Phase I/II Trial with Imatinib and Vinorelbine for Patients with Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|87|5|300-310

ISSN： 0030-2414

Source： Oncology, Vol.87, Iss.5, 2014-08, pp. : 300-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Weekly Combination of Docetaxel and Vinorelbine in Metastatic Breast Cancer: A Phase I/II Study

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 257-261

Karger

Access to resources Recommend Favorite

Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 1, 2000-03 ,pp. : 60-62

Karger

Access to resources Recommend Favorite

A Phase I Study of UFT-Oral Vinorelbine in Metastatic Breast Cancer

By  

Oncology, Vol. 81, Iss. 2, 2011-09 ,pp. : 73-78

Karger

Access to resources Recommend Favorite

An Open-Label, Noncomparative Phase II Trial to Evaluate the Efficacy and Safety of Docetaxel in Combination with Gefitinib in Patients with Hormone-Refractory Metastatic Prostate Cancer

By  

Oncology Research and Treatment, Vol. 30, Iss. 7, 2007-06 ,pp. : 355-360

Karger

Access to resources Recommend Favorite

A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines

By  

Oncology, Vol. 75, Iss. 3-4, 2008-10 ,pp. : 175-181

Karger

Access to resources Recommend Favorite